Christoph Bartoschek

Autolomous is a company founded by Cell and Gene Therapy (CGT)- and software development experts, who have combined their skills to deliver elegant, seamless and agile solutions to the CGT sector. Autolomous will deliver the digital solutions necessary for CGT to achieve scalability, allowing more patients to benefit from these life changing therapies. The company is creating a portfolio of software solutions (AutoloMATE-solution platform), from electronic Batch Manufacturing Records (eBMR) to enabling the scheduling of the patient blood collections at hospital; the transport of those cells to the manufacturing facilities; enhancing traceability throughout the manufacturing process; supporting compliance with current and future regulatory requirements; expediting the drug product release; and the scheduled delivery of the patient-specific medicine to the hospital. Our software will enable increased automation of these processes, reducing the risk of errors and ensuring that the correct product is returned to the right patient. AutoloMATE has been architected with agility, flexibility and adaptability in mind both for our customers for customization but also for our partners to integrate with our platform to create an end-to-end digital ecosystem. We’re looking for new team members. Are you a forward-thinking-digitally-minded individual? Do you want to be part of a meaningful and value-orientated company? Get in touch!

The Neteera System automates contactless patient and resident monitoring by measuring and tracking vital signs and activity metrics without wires, wearables, or patient compliance. Ambient radar sensor technology, combined with sophisticated algorithms, provides accurate, real-time patient insights. Our innovative monitoring and alert platform enhances patient care and comfort without cameras, microphones, clothing removal, or staff activation. Caregivers can stay ahead of patient conditions with smart alerts customized to desired thresholds and baseline deviations. Designed for most healthcare settings, Neteera technology is FDA-cleared and CE-certified by NB 2797. Simple, accurate, and secure—Neteera empowers healthcare providers to elevate patient care. Neteera was founded in 2015 by a group of hi-tech veteran executives, including Isaac Litman, the CEO of Mobileye (NYSE: MBLY) Aftermarket.

Scopio Labs is transforming cell morphology analysis, offering fully digital applications, platforms, and diagnostic support that enhance clinical workflows. By assisting lab experts with fast, early, and accurate detection and diagnosis of disease, Scopio expedites patients access to life-saving treatments. .

neurocare is innovating mental health and performance by personalizing therapy following a detailed assessment. neurocare’s objective, measurable and effective approach is based on our natural ability to learn (neuroplasticity) and technology to speed up the learning (neuromodulation). neurocare helps individuals to improve their self regulation and hence is a sustainable solution. The neurocare group provides a Digital Therapy Platform and Teletherapy and our vertical integration and know-how in Science, Neuromodulation Technology and clinical SOP’s is unique.

Ceidos developed the C-Netics to fully automate cell expansion monitoring in a closed system. This ensures better outcomes and reduces the process’ costs as contamination risk is prevented and manual handling is drastically reduced.

We help Parkinsons patients to maintain their mobility and autonomy

Cardiolyse is a cloud ECG & HRV analytics platform, that enables real-time remote heart health monitoring, providing plain personalized reports, detection and up to two months data-based prognosis on dangerous heart events. Our groundbreaking ECG analytic technology enables people 45+, their families, healthcare providers and insurance companies: - To get in-depth snapshot of cardiovascular system state and to monitor its trend; - Allows making six-month forecast of serious cardiovascular events; - To learn how current lifestyle is interconnected with heart conditions.

XO Life stands for ✅ a state-of-the-art platform solution for long-term Patient Insights from the real world ✅ real time information exchange between patients and pharma ✅ a all-in-one platform to be used across all treatments and indications We are a young and dynamic eHealth company setting a new standard patient data collection through scientifically based questionnaires across all treatments and medications. XO Life helps the pharmaceutical industry to better understand its patients. Our goal is to make digital treatment monitoring and patient feedback the gold standard in R&D, marketing and sales, while ensuring the highest data protection and security standards. ➡️ Join us in shaping the future of patient centered medical data collection and learn more at:

Autolomous is a company founded by Cell and Gene Therapy (CGT)- and software development experts, who have combined their skills to deliver elegant, seamless and agile solutions to the CGT sector. Autolomous will deliver the digital solutions necessary for CGT to achieve scalability, allowing more patients to benefit from these life changing therapies. The company is creating a portfolio of software solutions (AutoloMATE-solution platform), from electronic Batch Manufacturing Records (eBMR) to enabling the scheduling of the patient blood collections at hospital; the transport of those cells to the manufacturing facilities; enhancing traceability throughout the manufacturing process; supporting compliance with current and future regulatory requirements; expediting the drug product release; and the scheduled delivery of the patient-specific medicine to the hospital. Our software will enable increased automation of these processes, reducing the risk of errors and ensuring that the correct product is returned to the right patient. AutoloMATE has been architected with agility, flexibility and adaptability in mind both for our customers for customization but also for our partners to integrate with our platform to create an end-to-end digital ecosystem. We’re looking for new team members. Are you a forward-thinking-digitally-minded individual? Do you want to be part of a meaningful and value-orientated company? Get in touch!

The Neteera System automates contactless patient and resident monitoring by measuring and tracking vital signs and activity metrics without wires, wearables, or patient compliance. Ambient radar sensor technology, combined with sophisticated algorithms, provides accurate, real-time patient insights. Our innovative monitoring and alert platform enhances patient care and comfort without cameras, microphones, clothing removal, or staff activation. Caregivers can stay ahead of patient conditions with smart alerts customized to desired thresholds and baseline deviations. Designed for most healthcare settings, Neteera technology is FDA-cleared and CE-certified by NB 2797. Simple, accurate, and secure—Neteera empowers healthcare providers to elevate patient care. Neteera was founded in 2015 by a group of hi-tech veteran executives, including Isaac Litman, the CEO of Mobileye (NYSE: MBLY) Aftermarket.

Founded in 2010, ClearCut Medical Ltd. is an Israeli medical device company that develops technology and products for assisting in real-time tumor margin assessment inside the operating room. The company’s flag product is the ClearCoast™ system, a novel portable MRI scanner for assisting in intra-operative margin assessment during Breast Conserving Surgery (BCS). As of today, ClearCut Medical has conducted multiple clinical studies in Europe, United States, and Israel, performing hundreds of operations using the company’s systems. The ClearCoast™ system is easy to operate and intuitive to interpret without the need of any radiology or pathology expertise. The ClearCoast™ system is CE-marked and ready for commercial use, sales have already started in Europe during 2022, while in parallel, the company is working towards an FDA marketing authorization to expand its activity in the US.

Scopio Labs is transforming cell morphology analysis, offering fully digital applications, platforms, and diagnostic support that enhance clinical workflows. By assisting lab experts with fast, early, and accurate detection and diagnosis of disease, Scopio expedites patients access to life-saving treatments. .

neurocare is innovating mental health and performance by personalizing therapy following a detailed assessment. neurocare’s objective, measurable and effective approach is based on our natural ability to learn (neuroplasticity) and technology to speed up the learning (neuromodulation). neurocare helps individuals to improve their self regulation and hence is a sustainable solution. The neurocare group provides a Digital Therapy Platform and Teletherapy and our vertical integration and know-how in Science, Neuromodulation Technology and clinical SOP’s is unique.